RetiSpec is an AI-based company focused on early detection of neurodegenerative diseases through a simple eye exam. RetiSpec's proprietary AI solution leverages existing retinal imaging cameras to provide a non-invasive, accurate and scalable solution for the early detection of Alzheimer's disease. RetiSpec is involved in multiple Alzheimer's and brain health studies in leading hospitals and research networks throughout North America.
RetiSpec is currently advancing its regulatory and market entry plans for its first clinically-validated test to predict amyloid burden at the point of care, to aid in the evaluation of individuals for Alzheimer's disease and other causes of cognitive decline.
RetiSpec was recently selected from more than 75 global applicants to receive the Davos Alzheimer's Collaborative inaugural grant for Health System Preparedness to test its technology in optometry settings.
Company Details
- Employees
- 33
- Founded
- -
- Address
- Toronto, On, Ca
- he****@****pec.com
- Industry
- Software Development
- NAICS
-
Software Publishers
- Website
- retispec.com
- HQ
- Toronto, ON
Retispec Questions
Retispec's website is retispec.com
Retispec's LinkedIn profile is https://ca.linkedin.com/company/retispec
Retispec has
33 employees.
View email and phone details for 33
employees at Retispec.
Retispec's industry is
Software Development
Retispec's top competitors are
E-Zinc,
Phoenix,
Humi By Employment Hero,
My01,
Uride,
Rebel,
Contactmonkey,
Arteria Ai,
Relay,
7gen.
Retispec's support email address is hello@retispec.com
Retispec's categories are Software Development
Retispec's founding year is 2016
